XML 13 R2.htm IDEA: XBRL DOCUMENT v3.19.1
Interim Consolidated Balance Sheets - USD ($)
$ in Thousands
Mar. 31, 2019
Dec. 31, 2018
Current assets:    
Cash and cash equivalents $ 5,357 $ 5,238
Short-term investments 2,496
Restricted cash 4,249 25
Other current assets 995 568
Total current assets 13,097 5,831
Non-current assets:    
Fixed assets, net 248 259
Operating right-of-use assets 562
Total assets 13,907 6,090
Current liabilities:    
Trade payables 123 630
Lease liabilities 312
Accrued liabilities 548 755
Other accrued liabilities 3,446 3,375
Total current liabilities 4,429 4,760
Long-term liabilities:    
Long-term lease liabilities 250
Total liabilities 4,679 4,760
Commitments and contingencies
Shareholders' equity:    
Common stock of $0.01 par value; Authorized: 220,000,000 as of March 31, 2019 and December 31, 2018; issued and outstanding: 4,307,666 and 3,012,343 shares as of March 31, 2019, and December 31, 2018, respectively 43 31
Additional paid-in capital (*) [1] 42,385 32,538
Treasury shares (3,375) (3,375)
Accumulated deficit (*) [1] (29,825) (27,864)
Total stockholders' equity 9,228 1,330
Total liabilities and stockholders' equity $ 13,907 $ 6,090
[1] The Company adopted ASU 2017-11 using the full retrospective approach. Refer to Note 5 for further information.